Airway diseases
State of the art sessionChairs: O. Usmani (London, United Kingdom), A. Yorgancioglu (Konak, Turkey)
Aims: To evaluate the use of short-acting ß-2 agonist (SABA) monotherapy versus maintenance and reliever therapy (MART) and triple therapy for asthma; to describe new treatments for chronic cough; to determine the optimal endoscopic procedure for different patients with chronic obstructive pulmonary disease (COPD) and asthma; to discuss the role of artificial intelligence in asthma and COPD treatment.